Updated March 2016 – For more information on GcMAF, please join the GcMAF and GcMAF Cancer forums on Facebook – they are closed groups, so you have to wait for your membership to be confirmed. They contain up-to-date information on sources of GcMAF, and also feedback and contributions by people who are using GcMAF.
The news round-up from Google Alerts for Breast Cancer and Cancer, for the week ending 28 March 2014.
It’s an exciting week if you are a fan of peaches.
Yes, peaches are the latest drum roll in cancer-busting foods! If we are to believe the research, eating peaches could help inhibit breast cancer. Of course the study was conducted using (as usual) mice, and peach extract (i.e. more concentrated than the whole fruit itself), but the scientists claim the equivalent for a human would be a mere 3 peaches a day. I’m not convinced that the high sugar content of peaches is good for cancer patients, but if you’re already eating peaches, this is a good reason not to stop. It’s cheap, and you can find it in your supermarket aisle.
I had a hunt round for peach extract, and the only sources were peach powder and peach flavouring – I wonder which is the right one?
I’ve also discovered a study on peaches and breast cancer: “Polyphenolics from peach (Prunus persica var. Rich Lady) inhibit tumor growth and metastasis of MDA-MB-435 breast cancer cellsin vivo”
The other piece of news that caught my eye was about altering gut bacteria to minimise the side-effects of abdominal radiotherapy. Scientists suggest that faecal transplants might be one way of doing this. My interest in probiotics and gut flora, and in particular, Bravo Probiotic (which contains GcMAF) suggests that there are other less icky ways, and I think it’s a case of the right hand not knowing what the left hand is doing. Please read my posts on Bravo Probiotic (Maf314) and find out how it can maintain levels of immune cells CD4 and CD8 even through chemotherapy.
Other news of significance – two more pieces of research on triple-negative breast cancer, unfortunately still at the trial/mouse testing stage.